Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07739017 |
| Title | OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma (OPAL) |
| Acronym | OPAL |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Olivia Newton-John Cancer Research Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |